![Christine Chiou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christine Chiou
Investor Relations Kontakt bei
ZAI LAB LIMITED
Profil
Christine K.
Chiou is Senior Vice President & Head-Investor Relations at Zai Lab Ltd. since 2023.
Formerly, Ms. Chiou was Head-Investor Relations at Incyte Corp.
from 2019 to 2023, Principal at Merck & Co., Inc., Assistant Vice President & Equity Analyst at Barclays Capital, Inc. from 2011 to 2013, Research Analyst at Daiichi Sankyo, Inc. in 2010, Principal at GlaxoSmithKline LLC, and Investor Relations Contact at Allergan UC.
Education includes an MBA from The Trustees of Columbia University in The City of New York in 2009 and undergraduate studies at Bryn Mawr College.
Aktive Positionen von Christine Chiou
| Unternehmen | Position | Beginn |
|---|---|---|
| ZAI LAB LIMITED | Investor Relations Kontakt | 01.05.2023 |
Ehemalige bekannte Positionen von Christine Chiou
| Unternehmen | Position | Ende |
|---|---|---|
| INCYTE CORPORATION | Investor Relations Kontakt | 01.05.2023 |
| ALLERGAN PLC | Investor Relations Kontakt | 01.10.2019 |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.07.2013 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Corporate Officer/Principal | 30.11.2010 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Ausbildung von Christine Chiou
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bryn Mawr College
 Bryn Mawr College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Wählen Sie MarketScreener 
